Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.

Junqiang ChenT SuY LinB WangJ LiJ PanC Chen

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2017)

Paclitaxel plus nidaplatinum or lobaplatin is recommended in locally advanced ESCC due to their satisfying therapeutic effects and less toxicity. Tumor volume and maximum diameter of metastatic lymph nodes are independent prognostic factors in ESCC patients receiving IMRT and concurrent chemotherapy.

Keyphrases

locally advanced
prognostic factors
squamous cell carcinoma
rectal cancer
neoadjuvant chemotherapy
lymph node
phase ii study
radiation therapy
small cell lung cancer
oxidative stress
clinical trial
early stage
chemotherapy induced
replacement therapy